Gilpin Wealth Management’s Select Medical SEM Stock Holding History

Gilpin Wealth Management’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$347	Buy	21 +6	+40%	+$99	﹤0.01%	785
2026 Q1	$245	Buy	15 +7	+88%	+$110	﹤0.01%	810
2025 Q4	$119	Buy	+8	New	+$113	﹤0.01%	796

Other funds holding SEM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $19.7B AUM 39.39% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

DAM

Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Gilpin Wealth Management's SEM Position: Q2 2026 in Review

Gilpin Wealth Management increased its Select Medical (SEM) stake by 40% in Q2 2026, buying an estimated $99 and bringing the position to 21 shares worth $347. The position accounts for ﹤0.01% of the portfolio, ranked #785.

Gilpin Wealth Management first reported a position in SEM in Q4 2025 and has held it in 3 quarters since. 238 funds tracked by Wall St. Rank hold SEM as of Q2 2026.

Gilpin Wealth Management held 21 shares of Select Medical worth $347 as of Q2 2026.
Gilpin Wealth Management bought 6 Select Medical shares in Q2 2026, an estimated $99.
Select Medical made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q2 2026, its #785 holding.
Gilpin Wealth Management first reported a position in Select Medical in Q4 2025 and has held it in 3 quarters since.
238 funds tracked by Wall St. Rank held Select Medical as of Q2 2026.

Based on Gilpin Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.